NR1I2 and endothelial dysfunction: Moreover, dapagliflozin was shown to stimulate angiogenesis and endothelial cell proliferation by direct binding to the pregnane X receptor (PXR) [45] and protect from endothelial dysfunction by inhibiting sarco(endo)plasmic reticulum calcium-ATPase 2 (SERCA2) [37].